- Home
- TRVI vs AMBC Comparison
TRVI vs AMBC Comparison
Compare TRVI & AMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRVI
- AMBC
- Stock Information
- Founded
- TRVI 2011
- AMBC 1971
- Country
- TRVI United States
- AMBC United States
- Employees
- TRVI N/A
- AMBC N/A
- Industry
- TRVI Biotechnology: Pharmaceutical Preparations
- AMBC Property-Casualty Insurers
- Sector
- TRVI Health Care
- AMBC Finance
- Exchange
- TRVI Nasdaq
- AMBC Nasdaq
- Market Cap
- TRVI 383.4M
- AMBC 388.0M
- IPO Year
- TRVI 2019
- AMBC 1991
- Fundamental
- Price
- TRVI $6.50
- AMBC $8.64
- Analyst Decision
- TRVI Strong Buy
- AMBC Strong Buy
- Analyst Count
- TRVI 8
- AMBC 2
- Target Price
- TRVI $17.56
- AMBC $17.00
- AVG Volume (30 Days)
- TRVI 4.4M
- AMBC 1.7M
- Earning Date
- TRVI 03-18-2025
- AMBC 05-05-2025
- Dividend Yield
- TRVI N/A
- AMBC N/A
- EPS Growth
- TRVI N/A
- AMBC N/A
- EPS
- TRVI N/A
- AMBC N/A
- Revenue
- TRVI N/A
- AMBC $240,754,000.00
- Revenue This Year
- TRVI N/A
- AMBC N/A
- Revenue Next Year
- TRVI N/A
- AMBC N/A
- P/E Ratio
- TRVI N/A
- AMBC N/A
- Revenue Growth
- TRVI N/A
- AMBC 90.76
- 52 Week Low
- TRVI $2.30
- AMBC $7.92
- 52 Week High
- TRVI $7.39
- AMBC $18.45
- Technical
- Relative Strength Index (RSI)
- TRVI 66.37
- AMBC 33.41
- Support Level
- TRVI $6.22
- AMBC $8.24
- Resistance Level
- TRVI $6.79
- AMBC $9.17
- Average True Range (ATR)
- TRVI 0.40
- AMBC 0.34
- MACD
- TRVI -0.03
- AMBC 0.12
- Stochastic Oscillator
- TRVI 52.24
- AMBC 57.60
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.
About AMBC Ambac Financial Group Inc.
Ambac Financial Group Inc is a financial services holding company. It operates in two principal businesses segments: Insurance Distribution and Specialty Property & Casualty Insurance. Insurance Distribution segment includes Managing General Agents, Underwriters and other appointed and delegated underwriting businesses (collectively MGAs or MGA/Us), an insurance broker, and other distribution and underwriting businesses. Specialty Property & Casualty Insurance includes five carriers (collectively, Everspan). Key revenue is generated from Insurance Distribution.